261
Views
2
CrossRef citations to date
0
Altmetric
Letters to the Editor

Rebound of COVID-19 infection in patients with chronic lymphocytic leukemia treated for SARS-CoV-2 with Nirmatrelvir/Ritonavir or Molnupiravir

, , , &
Pages 1054-1056 | Received 14 Jan 2023, Accepted 19 Feb 2023, Published online: 13 Mar 2023
 

Author contributions

TT designed, organized, and wrote the manuscript. HA prepared the data and preprocessed the data, GM and TP, wrote the manuscript, LR designed, organized, performed the statistical analysis and wrote the manuscript.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Additional information

Funding

A grant from KSM- Maccabi Research and Innovation Center supported this study.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 1,065.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.